ENAVATUZUMAB
UNII 914910XFBB

Substance Identification & Data

This profile provides standardized clinical and technical data for Enavatuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 914910XFBB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1062149-33-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
914910XFBB
CAS Registry Number
1062149-33-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ENAVATUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C80045
National Cancer Institute reference terminology for clinical and research data.
INN ID
9354
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
XX-05
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enavatuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENAVATUZUMAB

Common Names & Synonyms

ENAVATUZUMAB [INN]
ENAVATUZUMAB [USAN]
ENAVATUZUMAB [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(TWEAK RECEPTOR) (HUMAN-MOUSE MONOCLONAL PDL192 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL PDL192 .KAPPA.-CHAIN, DIMER

Technical Codes

PDL 192
PDL-192

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus